![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
Inflammation and coronary artery disease
1Division of Cardiovascular Medicine, Jichi Medical School, Tochigi, Japan. uikeda@jichi.ac.jp
Current Vascular Pharmacology
|August 24, 2004
Summary
Atherosclerosis is an inflammatory disease where interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) indicate plaque vulnerability and risk for myocardial infarction. Targeting these inflammatory markers may prevent restenosis after procedures.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Research
Background:
- Atherosclerosis is fundamentally an inflammatory process.
- Interleukin-6 (IL-6) and C-Reactive Protein (CRP) reflect plaque inflammation and rupture risk.
- Monocyte chemoattractant protein-1 (MCP-1) is critical in initiating coronary artery disease and plaque instability.
Purpose of the Study:
- To investigate the role of IL-6 and MCP-1 in atherosclerosis, myocardial infarction, and post-PCI restenosis.
- To assess the correlation between plasma IL-6 and MCP-1 levels and cardiovascular events.
- To explore the therapeutic potential of targeting IL-6 and MCP-1.
Main Methods:
- Review of in vitro experiments, pathologic analyses, and epidemiologic studies.
- Analysis of plasma concentrations of IL-6 and MCP-1 in patients with various cardiovascular conditions.
- Correlation analysis of IL-6/MCP-1 levels with acute myocardial infarction, unstable angina, and restenosis after percutaneous coronary intervention (PCI).
Main Results:
- Elevated IL-6 and MCP-1 levels are observed in acute myocardial infarction and unstable angina, but not stable angina.
- Plasma IL-6 and MCP-1 concentrations increase after PCI.
- Increased IL-6 or MCP-1 levels post-PCI correlate with late restenosis, suggesting involvement in restenotic lesion formation.
Conclusions:
- IL-6 and MCP-1 are key inflammatory mediators in atherosclerosis and plaque instability.
- Elevated IL-6 and MCP-1 levels are associated with adverse cardiovascular events and post-PCI restenosis.
- Targeting IL-6 and MCP-1 presents a promising therapeutic strategy for preventing cardiovascular disease progression and restenosis.
Related Concept Videos
01:38Inflammation
Overview
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...